GlassScriptPhysician profile
Abhishek Challa
NPI 1477968659
$7,373.65
in general payments reported to CMS, 2019-2025
32 companies · $2,471 in 2025
The $2,471 reported for 2025 was more than what 83% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $1,667 · 2021: $593 · 2022: $151 · 2023: $903 · 2024: $1,376 · 2025: $2,471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,669 · Education: $81.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,669.02 |
| Education | $81.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $1,666.67 | 2020 | |
| Abbvie INC. | $1,583.19 | 2019-2025 | Rinvoq, Skyrizi, Mavyret |
| Janssen Biotech, INC. | $1,025.70 | 2023-2025 | Tremfya, Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $403.68 | 2021-2025 | Xifaxan, Trulance, Relistor |
| Medtronic, INC. | $296.60 | 2021 | |
| Pfizer INC. | $239.02 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $232.99 | 2024-2025 | Iqirvo |
| E.R. Squibb & Sons, L.L.C. | $199.28 | 2021-2022 | |
| Lilly USA, LLC | $155.61 | 2024-2025 | Omvoh |
| Takeda Pharmaceuticals U.S.A., INC. | $149.98 | 2023-2025 | Entyvio, Eohilia, Gattex |
| Genzyme Corporation | $148.78 | 2022-2025 | |
| Qol Medical, LLC | $138.40 | 2023-2025 | Sucraid |
| Celltrion USA INC. | $130.56 | 2023-2025 | Zymfentra, Vegzelma, Yuflyma |
| Aimmune Therapeutics, INC. | $118.62 | 2024-2025 | Vowst, Zenpep |
| Janssen Scientific Affairs, LLC | $116.86 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $110.30 | 2024-2025 | Voquezna |
| Madrigal Pharmaceuticals | $90.14 | 2024-2025 | Rezdiffra, Resmetirom |
| Echosens North America, INC. | $85.44 | 2025 | Fibroscan |
| Celgene Corporation | $80.55 | 2023 | Zeposia |
| Ardelyx, INC. | $71.45 | 2023-2025 | Ibsrela |
| Braintree Laboratories, INC. | $66.65 | 2023-2025 | Suflave, Sutab |
| Boston Scientific Corporation | $54.15 | 2021 | |
| Evoke Pharma, INC. | $33.39 | 2025 | |
| Merck Sharp & Dohme LLC | $33.39 | 2024 | Dificid |
| Gilead Sciences, INC. | $28.42 | 2025 | |
| Nestle Healthcare Nutrition INC. | $21.12 | 2023 | |
| Novo Nordisk INC | $19.16 | 2025 | Wegovy |
| Abbott Laboratories | $17.27 | 2021 | |
| Intercept Pharmaceuticals, INC. | $16.18 | 2024 | |
| Ironwood Pharmaceuticals, INC | $14.85 | 2024 | |
| Micro-Tech Endoscopy USA, INC. | $14.80 | 2025 | Forceps |
| Endogastric Solutions, INC | $10.45 | 2024 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhishek Challa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.